throid disorders/thyrotoxicosis

See Explanation

[]

Question 1 / 15
683b9e0331242d93219d2c8f

Endocrine

throid disorders

thyrotoxicosis

A 42-year-old male presents to the outpatient clinic reporting persistent fatigue, noticeable palpitations, and an unintentional 5 kg weight loss over the past several months. He also describes significant bilateral eye irritation, excessive tearing, and a feeling of grittiness. His past medical history is otherwise unremarkable. On physical examination, his temperature is 37.3°C, blood pressure is 145/85 mm Hg, pulse is 110/min and regular, and respirations are 19/min. Examination of his eyes reveals mild periorbital edema and scleral injection, with noticeable lid lag upon downward gaze but no obvious proptosis. His thyroid gland appears diffusely enlarged on palpation but is non-tender. The remainder of his physical examination is unremarkable. Initial laboratory results obtained a week prior showed a serum calcium level of 2.65 mmol/L (normal 2.18-2.58 mmol/L), with a suppressed parathyroid hormone level of 1.1 pmol/L (normal 1.6-9.3 pmol/L). His alkaline phosphatase was elevated at 215 IU/L (normal 50-136 IU/L). Considering the patient's comprehensive presentation and laboratory findings, including recent thyroid function tests, what is the most appropriate primary initial management strategy for his clinical presentation and the associated hypercalcemia?

Lab ParameterValueReference Range
Hemoglobin132 g/L125–170 g/L
Mean corpuscular volume82 fL80–100 fL
Creatinine75.00 µmol/L50–90 µmol/L
Calcium2.65 mmol/L2.18–2.58 mmol/L
Parathyroid hormone1.1 pmol/L1.6–9.3 pmol/L
1,25-dihydroxyvitamin D60 pmol/L64-226 pmol/L
25-hydroxyvitamin D70 nmol/L75–250 nmol/L
Alkaline phosphatase215 IU/L50–136 IU/L
Aspartate aminotransferase35 IU/L15–37 IU/L
Alanine aminotransferase30 IU/L17–63 IU/L
Thyroid Stimulating Hormone (TSH)0.01 mIU/L0.4-4.0 mIU/L
Free Thyroxine (FT4)35 pmol/L12-22 pmol/L

Edit question